CIK: 0000314957 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Jul 15, 2024
Total Value ($000): $129,724 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BND | VANGUARD BD INDEX FDS TOTAL BND MRKT | 766,763 | $55,245 | 42.6% | $77.46 | — | TOTAL BND MRKT | 921937835 |
| VT | VANGUARD INTL EQUITY INDEX F | 335,471 | $37,784 | 29.1% | $107.84 | — | TT WRLD ST ETF | 922042742 |
| VOO | VANGUARD INDEX FDS | 68,413 | $34,337 | 26.5% | $463.02 | — | S&P 500 ETF SHS | 922908363 |
| ABBV | ABBVIE INC COM | 6,000 | $1,029 | 0.8% | $157.12 | 0.0% | COM | 00287Y109 |
| NKGN | NKGEN BIOTECH INC | 550,000 | $699 | 0.5% | $3.23 | -56.7% | COM | 65488A101 |
| OVV | OVINTIV INC | 10,000 | $469 | 0.4% | $45.63 | +10.3% | COM | 69047Q102 |
| PYXS | PYXIS ONCOLOGY INC | 48,731 | $161 | 0.1% | $1.50 | +180.2% | COMMON STOCK | 747324101 |